Company / Cash per Share
X4 Pharmaceuticals, Inc Cash per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$38.09
FY2025
5-year range
$0.33 / $38.09
FY2021-FY2025
Trend
+11350.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +11350% YoY in FY2025, a notable deviation from the 5-year average annual change of +2398%.
Based on SEC 10-K filings.
38.09 in FY2025 with a 5-year CAGR of +137.5%.
Improved from $2.91 to $38.09 over the past 3 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +135.7%
- 5-Year CAGR
- +137.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 11350.3% year-over-year.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $38.09 | +11350.3% |
| FY2024 | $0.33 | -88.6% |
| FY2022 | $2.91 | -39.8% |
| FY2021 | $4.83 | +857.1% |
| FY2020 | $0.50 | -90.6% |
| FY2018 | $5.37 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026